EUVIMEDEUVIMED entdecken
Crossref

Synergistic activity of friedelan-3β-ol isolated from Euphorbia lactea and doxorubicin against MDA-MB-231 breast cancer cell line

Supusson Pengnam, Pawaris Wongprayoon, Panupun Limpachayaporn, Kanok‐on Rayanil, Purin Charoensuksai

Science, Engineering and Health Studies · 18.10.2022

DOI: 10.14456/sehs.2022.27 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, Engineering and Health Studies, erschienen am 18.10.2022. Verfasst von Supusson Pengnam und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cytotoxic activity of three triterpenoid compounds namely, friedelin [1], friedelan-3β-ol [2] and taraxerol [3] isolated from hexane fraction Euphorbia lactea Haw. was investigated in breast cancer cell lines MDA-MB-231 and MCF-7. Dose-dependent cytotoxic activity of these compounds was detected in MDA-MB-231 cells. Of the three compounds, [2] elicited the strongest inhibitory effect. The interplay between [2] and doxorubicin (Dox) in a series of combination treatments was analyzed in MDA-MB-231. Computer modeling software CompuSyn revealed that [2] and Dox exhibited a synergistic relationship over a broad range of concentration. The ratio of [2]:Dox at 25:1 µg/mL was predicted to achieve a 90% inhibitory effect with the lowest dose of each agent, thus allowing a dose reduction of [2] and Dox by ~30 and ~3 fold, respectively. Finally, the percentage of apoptotic cells in MDA-MB-231 treated with [2]:Dox at a 25:1 µg/mL combination was markedly higher than cells treated with 1x and 2x the concentration of each individual agent, supporting the predicted synergism. Together, the results highlighted [2] as an anticancer phytochemical exhibiting synergistic activity with Dox and warranted further research to assess the possibility to exploit this synergy for breast cancer treatment.

Schlagwörter

friedelintaraxeroldoxorubicinsynergistic drug combinationbreast cancerMDA-MB-231 cellsMCF-7 cellstriterpenoidscytotoxicityapoptosis

Zitieren

APA

Pengnam, S., Wongprayoon, P., Limpachayaporn, P., Rayanil, K., & Charoensuksai, P. (2022). Synergistic activity of friedelan-3β-ol isolated from Euphorbia lactea and doxorubicin against MDA-MB-231 breast cancer cell line. Science, Engineering and Health Studies. https://doi.org/10.14456/sehs.2022.27

Vancouver

Pengnam S, Wongprayoon P, Limpachayaporn P, Rayanil K, Charoensuksai P. Synergistic activity of friedelan-3β-ol isolated from Euphorbia lactea and doxorubicin against MDA-MB-231 breast cancer cell line. Science, Engineering and Health Studies. 2022. doi:10.14456/sehs.2022.27

BibTeX
@article{Pengnam2022,
  author = {Pengnam, Supusson and Wongprayoon, Pawaris and Limpachayaporn, Panupun and Rayanil, Kanok‐on and Charoensuksai, Purin},
  title = {Synergistic activity of friedelan-3β-ol isolated from Euphorbia lactea and doxorubicin against MDA-MB-231 breast cancer cell line},
  journal = {Science, Engineering and Health Studies},
  year = {2022},
  doi = {10.14456/sehs.2022.27}
}
Kostenlos starten →